KR102649112B1 - 인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 - Google Patents
인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 Download PDFInfo
- Publication number
- KR102649112B1 KR102649112B1 KR1020210159457A KR20210159457A KR102649112B1 KR 102649112 B1 KR102649112 B1 KR 102649112B1 KR 1020210159457 A KR1020210159457 A KR 1020210159457A KR 20210159457 A KR20210159457 A KR 20210159457A KR 102649112 B1 KR102649112 B1 KR 102649112B1
- Authority
- KR
- South Korea
- Prior art keywords
- sample
- line
- colon cancer
- diagnostic
- urine
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title claims abstract description 62
- 210000002700 urine Anatomy 0.000 title claims abstract description 39
- 238000009007 Diagnostic Kit Methods 0.000 title claims description 30
- 208000001333 Colorectal Neoplasms Diseases 0.000 title claims description 6
- 238000004519 manufacturing process Methods 0.000 title description 9
- 208000029742 colonic neoplasm Diseases 0.000 claims abstract description 57
- 102000029797 Prion Human genes 0.000 claims abstract description 25
- 108091000054 Prion Proteins 0.000 claims abstract description 25
- 238000012360 testing method Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 14
- 239000012528 membrane Substances 0.000 claims description 11
- 239000000020 Nitrocellulose Substances 0.000 claims description 6
- 229920001220 nitrocellulos Polymers 0.000 claims description 6
- 238000003745 diagnosis Methods 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 239000000356 contaminant Substances 0.000 claims description 2
- 238000004040 coloring Methods 0.000 claims 2
- 239000003550 marker Substances 0.000 abstract description 8
- 239000003147 molecular marker Substances 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 26
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 229920000742 Cotton Polymers 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000001900 immune effect Effects 0.000 description 6
- 238000003018 immunoassay Methods 0.000 description 6
- 238000003317 immunochromatography Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 210000004379 membrane Anatomy 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000002550 fecal effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 206010027476 Metastases Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 238000002052 colonoscopy Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019737 Animal fat Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 101710120463 Prostate stem cell antigen Proteins 0.000 description 1
- 102100036735 Prostate stem cell antigen Human genes 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000012143 endoscopic resection Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000004303 peritoneum Anatomy 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210159457A KR102649112B1 (ko) | 2021-11-18 | 2021-11-18 | 인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 |
| PCT/KR2022/007652 WO2023090553A1 (fr) | 2021-11-18 | 2022-05-30 | Kit de diagnostic pour diagnostiquer un cancer colorectal à l'aide d'urine humaine comme échantillon |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020210159457A KR102649112B1 (ko) | 2021-11-18 | 2021-11-18 | 인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20230072832A KR20230072832A (ko) | 2023-05-25 |
| KR102649112B1 true KR102649112B1 (ko) | 2024-03-20 |
Family
ID=86397181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020210159457A KR102649112B1 (ko) | 2021-11-18 | 2021-11-18 | 인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR102649112B1 (fr) |
| WO (1) | WO2023090553A1 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090246798A1 (en) * | 2008-03-25 | 2009-10-01 | Man-Sun Sy | Method of detecting cancer and evaluating cancer prognosis |
| US20140363825A1 (en) * | 2011-08-29 | 2014-12-11 | Kyoto University | Marker for detecting colorectal cancer or esophageal cancer and method for examining such cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101051435B1 (ko) * | 2008-10-22 | 2011-07-22 | 한국생명공학연구원 | 대장암 관련 마커를 이용한 대장암 진단 키트 및 이를 이용한 대장암 진단 방법 |
| KR101073875B1 (ko) * | 2008-11-28 | 2011-10-14 | 한국생명공학연구원 | 대장암 진단 마커 및 이를 이용한 대장암 진단방법 |
| JP2012018119A (ja) * | 2010-07-09 | 2012-01-26 | Toray Ind Inc | 大腸癌検出用マーカーおよびそれを用いた大腸癌検出方法 |
| KR101323371B1 (ko) * | 2011-05-03 | 2013-10-29 | 김수동 | 인간의 소변을 검체로 이용하여 전립선암을 진단하는 진단키트 및 그 제조방법 |
| KR101212024B1 (ko) | 2011-08-08 | 2012-12-13 | 한국생명공학연구원 | 대장암 및 전이에 대한 바이오마커, 이를 이용한 대장암 진단 및 치료제 스크리닝 |
| CN108603859B (zh) * | 2016-06-10 | 2021-06-18 | 株式会社日立制作所 | 尿中代谢物在制备癌的评价方法所使用的试剂盒中的用途 |
-
2021
- 2021-11-18 KR KR1020210159457A patent/KR102649112B1/ko active IP Right Grant
-
2022
- 2022-05-30 WO PCT/KR2022/007652 patent/WO2023090553A1/fr unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090246798A1 (en) * | 2008-03-25 | 2009-10-01 | Man-Sun Sy | Method of detecting cancer and evaluating cancer prognosis |
| US20140363825A1 (en) * | 2011-08-29 | 2014-12-11 | Kyoto University | Marker for detecting colorectal cancer or esophageal cancer and method for examining such cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023090553A1 (fr) | 2023-05-25 |
| KR20230072832A (ko) | 2023-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roda et al. | Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease | |
| Komoto et al. | Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology | |
| Morris et al. | Reliability of chemical tests for fecal occult blood in hospitalized patients | |
| CN104316685B (zh) | 一种二乙酰精胺的检测试剂盒及制备方法和应用 | |
| CN105527440A (zh) | 一种免疫层析试纸条及其制备方法与应用 | |
| US20080227208A1 (en) | Devices and Methods for Detection of Occult Blood | |
| CN108351358A (zh) | 肝癌测试方法 | |
| Noh et al. | Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases? | |
| CN204789589U (zh) | 一种胶体金检测试纸条 | |
| CN102043058A (zh) | 用于预测肿瘤的乙酰金刚烷胺的检测试剂盒 | |
| US20090305331A1 (en) | Kits and methods for determining colon cleanliness | |
| CN105717308A (zh) | 快速定量检测粪便乳铁蛋白的免疫层析试剂盒 | |
| CN106680515B (zh) | 用于肺癌诊断的多分子标志物组合 | |
| CN110361547A (zh) | 一种化学发光定量检测粪便潜血的试剂及其检测方法和其在检测下消化道健康的用途 | |
| CN112816693B (zh) | 一种用于结直肠癌早期筛查的试纸条 | |
| CN101493463B (zh) | 胃癌诊断试剂及其用途 | |
| KR102649112B1 (ko) | 인간의 소변을 검체로 이용하여 대장암을 진단하는 진단키트 | |
| CN206038688U (zh) | 一种免疫层析检测试纸条的荧光定量光谱检测系统 | |
| KR101083420B1 (ko) | 유방암 진단용 빈쿨린 자가항체 및 이를 이용한 진단키트 | |
| CN107144688B (zh) | Cd19阳性外泌体作为分子标记在制备肿瘤诊断试剂盒中的应用及试剂盒 | |
| CN109116023A (zh) | 一种肺癌标志物抗-mmp12自身抗体及其应用 | |
| KR20200102886A (ko) | 항-cyfra21-1 자가항체-항원 결합체 및 cyfra21-1 항원 마커의 검출방법 및 이들 마커의 비율을 이용한 폐암 진단키트 | |
| CN105259348A (zh) | 一种分泌型Sema4C蛋白及其应用 | |
| CN108593922A (zh) | 一种测定膀胱癌的联合检测试剂盒及其制备方法 | |
| Chen et al. | The value of biliary amylase and hepatocarcinoma–intestine–pancreas/pancreatitis-associated protein I (HIP/PAP-I) in diagnosing biliary malignancies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right |